logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Dr David John Grainger

child relation
Offspring entities and appointments 57
  • 1
    A BIO LIMITED
    13349556
    Active Corporate (5 parents)
    Officer
    2021-04-21 ~ now
    IIF 34 - Director → ME
    Person with significant control
    2021-04-21 ~ now
    IIF 4 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 4 - Right to appoint or remove directors → OE
    IIF 4 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 2
    ABC MEDICINES LIMITED
    09778579
    Dissolved Corporate (4 parents)
    Officer
    2015-09-15 ~ dissolved
    IIF 32 - Director → ME
    Person with significant control
    2016-04-06 ~ dissolved
    IIF 11 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 11 - Ownership of shares – More than 25% but not more than 50% → OE
  • 3
    AMPKINE LIMITED
    - now 12065717
    LITHIUM TX LIMITED
    - 2025-02-03 12065717
    HYDROGEN TX LIMITED
    - 2021-04-22 12065717
    Active Corporate (5 parents)
    Officer
    2019-06-24 ~ now
    IIF 49 - Director → ME
    Person with significant control
    2019-06-24 ~ 2025-04-17
    IIF 18 - Right to appoint or remove directors → OE
    IIF 18 - Ownership of shares – 75% or more → OE
    IIF 18 - Ownership of voting rights - 75% or more → OE
  • 4
    APCINTEX LIMITED
    - now 09088717
    SERPIN HAEMOSTATICS LIMITED
    - 2016-04-02 09088717
    Active Corporate (19 parents)
    Officer
    2014-06-16 ~ 2016-12-07
    IIF 59 - Director → ME
  • 5
    BARKWAY HOUSE ESTATES LIMITED
    13307945
    Active Corporate (2 parents, 5 offsprings)
    Officer
    2021-04-01 ~ now
    IIF 41 - Director → ME
    Person with significant control
    2021-04-01 ~ now
    IIF 64 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 64 - Ownership of shares – More than 25% but not more than 50% → OE
  • 6
    BHE ALTAIR LTD
    13311920
    Active Corporate (3 parents)
    Officer
    2021-04-03 ~ now
    IIF 44 - Director → ME
  • 7
    BHE BETELGEUSE LTD
    13312281
    Active Corporate (3 parents)
    Officer
    2021-04-03 ~ now
    IIF 43 - Director → ME
    Person with significant control
    2026-04-14 ~ now
    IIF 7 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 7 - Ownership of shares – More than 25% but not more than 50% → OE
    2022-11-02 ~ 2026-04-14
    IIF 13 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 13 - Ownership of shares – More than 25% but not more than 50% → OE
  • 8
    BHE CAPELLA LTD
    13311663
    Active Corporate (3 parents)
    Officer
    2021-04-03 ~ now
    IIF 42 - Director → ME
  • 9
    BHE DENEB LTD
    13455018
    Active Corporate (3 parents)
    Officer
    2021-06-14 ~ now
    IIF 55 - Director → ME
    Person with significant control
    2022-10-17 ~ now
    IIF 9 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 9 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 10
    BHE ELECTRA LTD
    16940160
    Active Corporate (3 parents)
    Officer
    2026-01-02 ~ now
    IIF 51 - Director → ME
  • 11
    BPLETE LIMITED
    - now 13439199
    PROTEOMX LIMITED
    - 2023-11-17 13439199
    Active Corporate (4 parents)
    Officer
    2021-06-04 ~ now
    IIF 35 - Director → ME
    Person with significant control
    2021-06-04 ~ 2023-11-09
    IIF 3 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 3 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 3 - Right to appoint or remove directors → OE
  • 12
    C21MED I LLP
    OC424406
    Dissolved Corporate (2 parents)
    Officer
    2018-10-09 ~ dissolved
    IIF 65 - LLP Designated Member → ME
    Person with significant control
    2018-10-09 ~ dissolved
    IIF 14 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 14 - Right to appoint or remove members → OE
    IIF 14 - Right to surplus assets - More than 25% but not more than 50% → OE
  • 13
    CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED
    - now 09686738
    MORPHOGEN-IX LIMITED
    - 2023-04-03 09686738
    Dissolved Corporate (15 parents)
    Officer
    2015-07-15 ~ 2021-01-29
    IIF 38 - Director → ME
    2021-11-30 ~ 2023-08-18
    IIF 19 - Director → ME
  • 14
    CENTESSA PHARMACEUTICALS (OREXIA) LIMITED
    - now 11607013
    OREXIA THERAPEUTICS LIMITED
    - 2023-04-03 11607013
    OREXIA LIMITED - 2021-02-24
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 24 - Director → ME
  • 15
    CORRECTA4 BIO LIMITED
    10132532
    Dissolved Corporate (4 parents)
    Officer
    2016-04-19 ~ dissolved
    IIF 26 - Director → ME
  • 16
    CRITICAL PRESSURE LIMITED
    10826367
    Liquidation Corporate (7 parents)
    Officer
    2017-10-02 ~ 2021-11-24
    IIF 46 - Director → ME
  • 17
    DC EUROPA LIMITED
    10826961
    Dissolved Corporate (9 parents)
    Officer
    2017-06-20 ~ dissolved
    IIF 27 - Director → ME
  • 18
    ELEMENTS SQUARED LIMITED
    12065441
    Active Corporate (8 parents, 5 offsprings)
    Person with significant control
    2019-06-24 ~ 2019-08-02
    IIF 16 - Right to appoint or remove directors → OE
    IIF 16 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 16 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 19
    EPSILON-3 BIO LIMITED
    - now 07289096
    APOE TECHNOLOGIES LIMITED
    - 2012-01-17 07289096
    Dissolved Corporate (14 parents)
    Officer
    2010-06-25 ~ dissolved
    IIF 77 - Director → ME
  • 20
    FINGERPRINT DIAGNOSTICS LTD
    04540637
    Dissolved Corporate (7 parents)
    Officer
    2002-09-20 ~ 2006-06-28
    IIF 68 - Director → ME
  • 21
    FUNXIONAL THERAPEUTICS LIMITED
    05534392
    Dissolved Corporate (19 parents)
    Officer
    2007-12-14 ~ 2013-02-01
    IIF 74 - Director → ME
    2014-09-01 ~ dissolved
    IIF 62 - Director → ME
    2005-08-11 ~ 2006-10-31
    IIF 71 - Director → ME
  • 22
    HUMAN ANTIBODY FACTORY LIMITED
    09812386
    Dissolved Corporate (5 parents)
    Officer
    2015-10-06 ~ dissolved
    IIF 30 - Director → ME
  • 23
    IMHOTEX LIMITED
    12443280
    Active Corporate (5 parents)
    Officer
    2020-02-05 ~ now
    IIF 48 - Director → ME
    Person with significant control
    2020-02-05 ~ 2020-03-02
    IIF 17 - Right to appoint or remove directors → OE
    IIF 17 - Ownership of shares – 75% or more → OE
    IIF 17 - Ownership of voting rights - 75% or more → OE
  • 24
    INEXIA LIMITED
    11607985
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 20 - Director → ME
  • 25
    INHIBITAXIN LIMITED
    08582765
    Dissolved Corporate (8 parents)
    Officer
    2013-06-25 ~ dissolved
    IIF 56 - Director → ME
  • 26
    JANPIX LIMITED
    08709519
    Dissolved Corporate (14 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 25 - Director → ME
  • 27
    JOHNS THERAPEUTICS LIMITED
    - now 06327059 07949383
    PROTEXA THERAPEUTICS LIMITED
    - 2012-03-06 06327059 07949383
    BETA THERAPEUTICS LIMITED
    - 2009-09-21 06327059
    Dissolved Corporate (3 parents)
    Officer
    2007-07-27 ~ dissolved
    IIF 75 - Director → ME
  • 28
    LEVICEPT LTD
    08190142
    Active Corporate (12 parents)
    Officer
    2012-08-23 ~ 2018-06-11
    IIF 73 - Director → ME
  • 29
    LOCKBODY THERAPEUTICS LTD
    - now 10650186
    ULTRAHUMAN SIX LIMITED - 2020-11-15
    Dissolved Corporate (15 parents, 2 offsprings)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 23 - Director → ME
  • 30
    MEDICXI VENTURES (UK) LLP
    OC402437
    Active Corporate (9 parents)
    Officer
    2016-01-25 ~ 2017-12-31
    IIF 67 - LLP Member → ME
  • 31
    METHUSELAH HEALTH UK LIMITED
    09209003
    Active Corporate (9 parents)
    Officer
    2014-09-09 ~ now
    IIF 60 - Director → ME
  • 32
    ONCOMET LIMITED
    08424564
    Dissolved Corporate (4 parents)
    Officer
    2013-02-28 ~ dissolved
    IIF 61 - Director → ME
  • 33
    PANDEIA THERAPEUTICS LIMITED
    11463856
    Active Corporate (10 parents)
    Officer
    2019-09-19 ~ 2022-12-22
    IIF 40 - Director → ME
  • 34
    PERFECT BALANCE BIO LIMITED
    12885832
    Active Corporate (4 parents)
    Officer
    2020-09-17 ~ now
    IIF 39 - Director → ME
    Person with significant control
    2020-09-17 ~ 2020-10-23
    IIF 6 - Ownership of voting rights - 75% or more → OE
    IIF 6 - Right to appoint or remove directors → OE
    IIF 6 - Ownership of shares – 75% or more → OE
  • 35
    PRONOSTICS LIMITED
    - now 03908499
    SMARTBEAD TECHNOLOGIES LIMITED
    - 2006-12-01 03908499
    SKAR INSTRUMENTS LIMITED - 2000-10-05
    Dissolved Corporate (18 parents)
    Officer
    2006-06-28 ~ 2008-12-16
    IIF 69 - Director → ME
  • 36
    PROTEXA THERAPEUTICS LIMITED
    - now 07949383 06327059
    JOHNS THERAPEUTICS LIMITED
    - 2012-03-06 07949383 06327059
    Dissolved Corporate (2 parents)
    Officer
    2012-02-14 ~ dissolved
    IIF 78 - Director → ME
  • 37
    PURPLE PHARMACEUTICALS LIMITED
    08608036
    Dissolved Corporate (7 parents)
    Officer
    2013-07-12 ~ dissolved
    IIF 50 - Director → ME
  • 38
    REBALANCE (CAMBRIDGE) LIMITED
    10512909
    Dissolved Corporate (5 parents)
    Officer
    2016-12-06 ~ dissolved
    IIF 57 - Director → ME
  • 39
    ROUND EARTH THERAPEUTICS LIMITED
    - now 11966376
    G4X LTD
    - 2019-08-09 11966376
    Dissolved Corporate (7 parents)
    Officer
    2019-08-08 ~ dissolved
    IIF 47 - Director → ME
  • 40
    RXBIOLOGICS LIMITED
    - now 10590235
    RX&D LIMITED
    - 2019-02-07 10590235
    Active Corporate (5 parents)
    Officer
    2017-03-01 ~ now
    IIF 52 - Director → ME
  • 41
    RXCELERATE LIMITED
    - now 08284658
    TCP BIOTECH LIMITED
    - 2013-02-05 08284658
    Active Corporate (8 parents, 6 offsprings)
    Officer
    2012-11-07 ~ now
    IIF 53 - Director → ME
  • 42
    S XPRESS BIO LIMITED
    - now 12216115
    HYDROGEN THERAPEUTICS LIMITED
    - 2025-02-13 12216115
    HELIUM TX LIMITED
    - 2021-04-28 12216115
    Active Corporate (5 parents)
    Officer
    2019-09-25 ~ now
    IIF 37 - Director → ME
    Person with significant control
    2019-09-19 ~ 2020-04-29
    IIF 15 - Ownership of shares – 75% or more → OE
    IIF 15 - Right to appoint or remove directors → OE
    IIF 15 - Ownership of voting rights - 75% or more → OE
  • 43
    SDS THERAPEUTICS LIMITED
    12719780
    Active Corporate (6 parents)
    Officer
    2020-07-05 ~ 2024-01-17
    IIF 36 - Director → ME
    Person with significant control
    2020-07-05 ~ 2020-12-18
    IIF 5 - Ownership of shares – 75% or more → OE
    IIF 5 - Right to appoint or remove directors → OE
    IIF 5 - Ownership of voting rights - 75% or more → OE
  • 44
    STEALTHYX THERAPEUTICS LIMITED
    04491233
    Liquidation Corporate (18 parents)
    Officer
    2014-12-02 ~ 2017-10-31
    IIF 33 - Director → ME
  • 45
    SUPERX LIMITED
    09865177
    Dissolved Corporate (13 parents)
    Officer
    2015-11-10 ~ 2016-01-07
    IIF 31 - Director → ME
  • 46
    TCP ASSET 1 LLP
    - now OC352240
    THE CAMBRIDGE PARTNERSHIP LLP
    - 2013-02-19 OC352240 OC347357... (more)
    TOTAL MEDICAL VENTURES I LLP
    - 2010-02-11 OC352240 OC347357
    Dissolved Corporate (3 parents)
    Officer
    2010-02-11 ~ dissolved
    IIF 72 - LLP Designated Member → ME
  • 47
    TCP INNOVATIONS LIMITED
    04333576
    Dissolved Corporate (8 parents, 5 offsprings)
    Officer
    2001-12-05 ~ dissolved
    IIF 79 - Director → ME
  • 48
    THE CAMBRIDGE PARTNERSHIP LIMITED
    - now 08288375 OC352240... (more)
    TCPI ASSET 1 LIMITED - 2013-04-10
    Active Corporate (5 parents, 68 offsprings)
    Officer
    2014-11-01 ~ now
    IIF 54 - Director → ME
    Person with significant control
    2016-04-06 ~ 2018-04-30
    IIF 10 - Ownership of shares – More than 25% but not more than 50% → OE
  • 49
    THE FOUNDRY (CAMBRIDGE) LIMITED
    - now 10822408
    DC GANYMEDE LIMITED
    - 2018-01-15 10822408
    Active Corporate (2 parents, 1 offspring)
    Officer
    2017-06-16 ~ now
    IIF 28 - Director → ME
    Person with significant control
    2018-01-01 ~ now
    IIF 8 - Right to appoint or remove directors → OE
    IIF 8 - Ownership of shares – 75% or more → OE
    IIF 8 - Ownership of voting rights - 75% or more → OE
  • 50
    TOTAL DIAGNOSTICS LIMITED
    09507375
    Dissolved Corporate (2 parents)
    Officer
    2015-03-24 ~ dissolved
    IIF 45 - Director → ME
    Person with significant control
    2016-04-06 ~ dissolved
    IIF 1 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 1 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 51
    TOTAL MEDICAL VENTURES I LLP
    - now OC347357 OC352240
    THE CAMBRIDGE PARTNERSHIP LLP
    - 2010-02-11 OC347357 OC352240... (more)
    Active Corporate (2 parents, 2 offsprings)
    Officer
    2009-07-23 ~ now
    IIF 66 - LLP Designated Member → ME
    Person with significant control
    2016-04-06 ~ now
    IIF 12 - Right to surplus assets - More than 25% but not more than 50% → OE
    IIF 12 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 12 - Has significant influence or control → OE
  • 52
    TOTAL SCIENTIFIC LIMITED
    05952429
    Dissolved Corporate (7 parents)
    Officer
    2012-01-05 ~ dissolved
    IIF 76 - Director → ME
    2006-10-02 ~ 2007-12-18
    IIF 70 - Director → ME
    Person with significant control
    2016-04-06 ~ 2018-04-30
    IIF 2 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 2 - Ownership of shares – More than 25% but not more than 50% → OE
  • 53
    ULTRAHUMAN FOUR LIMITED
    10650089
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 22 - Director → ME
  • 54
    ULTRAHUMAN LIMITED
    09885211
    Dissolved Corporate (10 parents)
    Officer
    2015-11-24 ~ 2016-01-19
    IIF 29 - Director → ME
  • 55
    ULTRAHUMAN TWO LIMITED
    10645698
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 21 - Director → ME
  • 56
    XO1 LIMITED
    08424622
    Dissolved Corporate (21 parents)
    Officer
    2013-02-28 ~ 2015-03-18
    IIF 58 - Director → ME
  • 57
    Z FACTOR LIMITED
    09274181
    Dissolved Corporate (14 parents)
    Officer
    2014-10-21 ~ 2021-01-29
    IIF 63 - Director → ME

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.